Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › TNXP Leadership & Pay · Jul 21, 2026
Dr. Gregory M. Sullivan will retire from his role as Chief Medical Officer, effective August 20, 2026 TNXP Tonix Pharmaceuticals Holding Corp.
Dr. Gregory M. Sullivan will retire from his role as Chief Medical Officer, effective August 20, 2026. Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and treating various medical conditions.
More from Tonix Pharmaceuticals Holding Corp. Tonix estimates $14M-$15M in TONMYA revenue for Q3 2026 Oct 15, 2026 Dr. Reddy’s files Paragraph IV ANDA for Tonix’s TONMYA, triggering potential 30-month stay Oct 2, 2026 Tonix Pharmaceuticals Holding Corp. announced a new managed Medicare payer agreement for its fibromyalgia treatment… Sep 22, 2026 Tonix Pharmaceuticals Holding Corp. announced on September 8, 2026, the promotion of Thomas Englese to Chief… Sep 8, 2026 On August 18, 2026, Tonix Pharmaceuticals Holding Corp. appointed President and CEO Dr. Seth Lederman as Interim Chief… Aug 18, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
